Clinical Trial Detail

NCT ID NCT04493619
Title PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer
Recruitment Not yet recruiting
Gender female
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Plexxikon
Indications

ovary epithelial cancer

uterine cancer

ovarian cancer

cervical cancer

vulva cancer

peritoneum cancer

fallopian tube cancer

vaginal cancer

Therapies

Carboplatin + PLX2853

PLX2853

Age Groups: adult senior

Additional content available in CKB BOOST